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Department of Signal Transduction, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague,
Czech Republic
The plasma membrane contains diverse and specialized membrane domains, which
include tetraspanin-enriched domains (TEMs) and transmembrane adaptor protein
(TRAP)-enriched domains. Recent biophysical, microscopic, and functional studies
indicated that TEMs and TRAP-enriched domains are involved in compartmentalization
of physicochemical events of such important processes as immunoreceptor signal
transduction and chemotaxis. Moreover, there is evidence of a cross-talk between TEMs
and TRAP-enriched domains. In this review we discuss the presence and function of
such domains and their crosstalk using mast cells as a model. The combined data based
on analysis of selected mast cell-expressed tetraspanins [cluster of differentiation (CD)9,
CD53, CD63, CD81, CD151)] or TRAPs [linker for activation of T cells (LAT), non-T cell
activation linker (NTAL), and phosphoprotein associated with glycosphingolipid-enriched
membrane microdomains (PAG)] using knockout mice or specific antibodies point to a
diversity within these two families and bring evidence of the important roles of these
molecules in signaling events. An example of this diversity is physical separation of
two TRAPs, LAT and NTAL, which are in many aspects similar but show plasma
membrane location in different microdomains in both non-activated and activated cells.
Although our understanding of TEMs and TRAP-enriched domains is far from complete,
pharmaceutical applications of the knowledge about these domains are under way.
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INTRODUCTION
The plasma membrane, as well as other cellular membranes, is a very complex structure composed
of a plethora of proteins and a variety of lipids organized into two asymmetrical leaflets. The proper
function of cellular membranes depends on the composition of the leaflets and intermolecular
communication of the membrane components. This is especially important in such complex
processes as signal transduction from plasma membrane receptors into the cytoplasm and nucleus.
Cellular membranes play a key role in signal transduction in both directions, inside-out and
outside-in. For years it has been thought that the lipid composition of the membrane allows
formation of signaling platforms that are critical for membrane functioning and that membrane
lipids and proteins play key roles as membrane organizers (Singer and Nicolson, 1972; van Meer
et al., 2008; Simons and Gerl, 2010; Treanor and Batista, 2010; Simons and Sampaio, 2011).
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Many systems have been used to study the structure-function
relationships of the plasma membrane components. Among
them are mast cells (MCs) or MC lines. MCs are effector cells
of the immune system that are able to react to external stimuli
by rapid release of numerous allergy mediators from cytoplasmic
granules and/or by production and secretion of a variety of
cytokines and chemokines. Activation of MCs is initiated by
binding of ligands [e.g., antigens (Ags)] to plasma membrane
receptors or their complexes [e.g., immunoglobulin (Ig)E bound
to high-affinity IgE receptor (FcεRI)]. This binding initiates cell
activation events, which involve a number of signal transduction
molecules forming functionally and spatially connected units,
called signalosomes. Receptor-mediated responses vary in
strength and duration. For example, aggregation of FcεRIs by
multimeric Ag-IgE complexes leads to phosphorylation of several
proteins, followed by Ca2+ response, in seconds after triggering,
release of pre-formed granules containing various mediators, in
minutes after activation, and ending by de novo synthesis of lipid
mediators, cytokines and chemokines in tens of minutes and
hours after activation (reviewed in Marshall, 2004; Galli et al.,
2008; Kalesnikoff and Galli, 2008; Galli and Tsai, 2012). These
signaling events could have dramatic physiological consequences,
such as causing allergy disease (Galli and Tsai, 2012) or breaking
down poison in snake venom (Metz et al., 2006), and therefore
must be precisely regulated (Galli, 2016). There are numerous
signal transduction regulators localized in the plasmamembrane,
membrane proximal, in the endoplasmic reticulum, as well as
in the cytoplasm. This review is focused on two groups of
transmembrane proteins that are involved in plasma membrane
receptor regulation and functioning. The first group consists
of tetraspanins, which span the plasma membrane four times
and form two extracellular domains and short intracellular tails.
The second group consists of transmembrane adaptor proteins
(TRAPs), which possess a short extracellular domain, one
transmembrane domain and a long intracellular tail with several
tyrosines that once phosphorylated can serve as anchor for
different proteins and in this way influence signal transduction.
Although these two groups of proteins are structurally different,
they share some common properties, such as palmitoylation and
ability to interact with a plethora of plasma membrane-bound
or intracellular proteins. Furthermore, recent studies with MCs
found a cross-talk between proteins in these two groups in the
regulation of plasma membrane-bound signaling events (Hálová
et al., 2013).
TETRASPANINS
Tetraspanins are an evolutionarily conserved superfamily of
transmembrane proteins with characteristic features. They have
four transmembrane domains and two extracellular loops, a small
one (SEL) and a large one (LEL). LEL possesses a conserved
CCG motif and at least two other cysteine residues that form
disulfide bonds inside the LEL domain (Figure 1). There are two
main post-translational modifications occurring in tetraspanins.
Most of them possess one or more N-glycosylation sites at
the LEL domain with two exceptions, cluster of differentiation
(CD)9, which possesses an N-glycosylation site in SEL, and
CD81, which is non-glycosylated (Boucheix and Rubinstein,
2001). Interestingly, all of the so far studied tetraspanins contain
a palmitoylation site (Charrin et al., 2002; Yang et al., 2002,
2004). Palmitoylation is a modification that tetraspanins share
with a plethora of other transmembrane or membrane-associated
proteins, such as TRAPs [including linker for activation of T
cells (LAT), non-T cell activation linker (NTAL; also called
LAT2), and phosphoprotein associated with glycosphingolipid-
enriched membrane microdomains (PAG; also called CSK-
binding proteins)] (Draber et al., 2011a; Stepanek et al., 2014),
integrins (Berditchevski, 2001; Gagnoux-Palacios et al., 2003;
Yang et al., 2004), SRC kinases (Kovárˇová et al., 2001; Gilfillan and
Rivera, 2009), and others. Examples of palmitoylated proteins
expressed on the MC membrane are presented in Figure 1.
Palmitoylation is important for the protein topography and its
functioning in the plasma membrane (see below).
Tetraspanins are known regulators of cell migration
(Boucheix and Rubinstein, 2001) and are involved in tumor
progression and metastasis (Zöller, 2009). Some tetraspanins
such as CD82, and often also CD9, are downregulated in
advanced stages of cancer; their absence is a sign of poor
prognosis in patients with several types of cancer. These
tetraspanins are considered as tumor suppressors. However,
some other tetraspanins, such as CD151 and TSPAN8, have
been found upregulated in metastases and their upregulation
was associated with poor prognosis, suggesting that they serve
as tumor promotors (reviewed in Zöller, 2009). The authors
speculated that the different roles of tetraspanins in tumor
progression could be the result of specific tetraspanin abundance
in exosomes. This could positively or negatively influence
the fusion of exosomes with plasma membranes in partner
cells, depending on the tetraspanin type. In this way exosomes
possessing different tetraspanins could exhibit different delivery
of important communicators such as mRNA and microRNA
and also proteins important in cell-cell communication (Zöller,
2009).
Several tetraspanins display broad tissue expression (e.g.,
CD9, CD81, CD151), whereas others are restricted e.g., to
leukocytes (CD37, CD53). Only a few tetraspanins (UP1a, UP1b,
peripherin and ROM-1) have their distribution limited to specific
tissue (Tarrant et al., 2003; Charrin et al., 2009, 2014). Although
tetraspanins are abundant proteins in many cell types, animals
deficient in selected tetraspanins usually do not exhibit striking
phenotypes, probably due to the redundancy and functional
compensation of individual tetraspanins. On the other hand,
mutations in individual tetraspanin genes have been described
as a cause of several life-threatening diseases (Kajiwara et al.,
1993, 1994; Zemni et al., 2000; Karamatic et al., 2004; van Zelm
et al., 2010). In some cases, mice lacking a particular tetraspanin
mimicked the phenotype observed in humans with a defect in the
same tetraspanin (Hemler, 2005).
Although several tetraspanins (CD9, CD37, CD53, CD63,
CD81, CD82, CD151) are abundantly expressed on the plasma
membrane of MCs and/or secretory vesicles (Table 1), their
role in MC physiology and activation events is not completely
understood. The problem is that for some tetraspanins there
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FIGURE 1 | Involvement of TEMs and TRAP-enriched domains in FcεRI signalosome. At the level of the plasma membrane, there is a cross-talk of FcεRI,
consisting of four transmembrane subunits (α,β, and γγ), with tetraspanins and TRAPs. These interactions affect FcεRI signal transduction. Phosphorylated ITAMs of
FcεRI bind LYN kinase, which is connected to the membrane by palmitoylation and myristoylation. Two important TRAPs, NTAL and LAT, which occupy different
nanodomains, are also palmitoylated. Tetraspanins are represented by CD9, which contains six palmitoylation domains and one possible glycosylation site in a small
intracellular loop, two disulfide bonds and tetraspanin conserved motif CCG are also depicted in the figure. Finally, integrins are represented by palmitoylated α4β1 that
is located in close proximity of CD9. The membrane is connected with the actin cytoskeleton through the FERM (4.1,ezrin/radixin/moesin) domain and actin-binding
domain (Abd) of ERM proteins. FERM binds directly to phosphatidylinositol 4 5-bisphosphate (PIP2).
are no commercially available antibodies and/or knockout (KO)
animals for such studies. The role of tetraspanins in MCs was
reviewed in 2012 (Köberle et al., 2012) and since then, several
new studies have appeared highlighting the significance of these
membrane organizers in MC physiology. The novel findings are
summarized below.
CD9
Although CD9 KO mice have been prepared (Le Naour et al.,
2000), they have not been used for the studies of the role of
CD9 in MC physiology. Thus, our knowledge about the role
of CD9 in MCs comes mainly from the studies using CD9-
specific antibodies. Our recent study described a new CD9-
specific monoclonal antibody (mAb), 2H9, which caused mast
cell degranulation, Ca2+ release and tyrosine phosphorylation of
several proteins including TRAP NTAL and dephosphorylation
of ezrin/radixin/moesin (ERM) family proteins (Hálová et al.,
2013). Phosphorylation of NTAL was brought about by complete
antibody but not its F(ab)2 fragment, suggesting that the Fc
fragment of the antibody is involved. Further studies showed that
2H9 antibody produced NTAL phosphorylation in cooperation
with FcγRs through SRC family kinase LYN, and that CD9 and
NTAL co-localized in the same membrane microdomains after
antibody-induced CD9 aggregation. A previous study showed
that antibody-induced aggregation of human CD9 expressed in
CD9-negative rat basophilic leukemia (RBL) cells, clone 2H3, also
caused degranulation, but its F(ab)2 fragment not (Higginbottom
et al., 2000). The authors speculated that CD9 and FcεRI form
complexes, and therefore crosslinking by anti-CD9 antibody
induced activation by a mechanism similar to the one induced by
aggregation of FcεRI. However, experiments with bone marrow-
derivedmast cells (BMMCs) showed that CD9 did not co-localize
with FcεRI in non-activated cells, but dimerization of CD9 with
bivalent antibody induced movement of CD9 into the close
proximity of FcεRI (Figure 2). This co-localization was further
strengthened by crosslinking of CD9-anti-CD9 complexes with
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TABLE 1 | Selected tetraspanins expressed in mast cells and their function.
Gene
symbol
Most used aliases KO Phenotype of KO mice, general/in mast cells Other important functions in mast
cells
CD9 BTCC-1, DRAP-27,
MIC3, MRP-1,
TSPAN-29,
TSPAN29
Le Naour et al., 2000 Deficiency in sperm-egg fusion (Kaji et al., 2000; Le
Naour et al., 2000; Miyado et al., 2000; Wright et al.,
2004)/not studied
Antibodies against CD9 block MCs
migration toward IL-16 (Qi et al., 2006)
and Ag (Hálová et al., 2013) and
induce Ca2+ release and
phosphorylation of several substrates
(Hálová et al., 2013)
CD37 GP52-40, TSPAN26 Knobeloch et al., 2000 Mild alteration of immune system (Knobeloch et al.,
2000)/normal levels of IgE, MCs not particularly
studied (Knobeloch et al., 2000)
CD53 MOX44, Ox-44,
TSPAN25
Associated with population asthma
risk but not directly connected to MCs
(Lee et al., 2013)
CD63 LAMP-3, ME491,
MLA1, OMA81H,
TSPAN30
Schröder et al., 2009 Mild defects, altered water balance (Schröder et al.,
2009)/reduced degranulation, TNF-α secretion, and
PCA (Kraft et al., 2013)
Antibody against CD63 suppresses
degranulation and PCA (Kraft et al.,
2005)
CD81 TAPA-1, CVID6,
S5.7, TSPAN28
Maecker and Levy, 1997 Female infertility (Rubinstein et al., 2006), nervous
system malfunctions (Geisert et al., 2002), reduced
IL-4 production (Maecker et al., 1998), lower
expression of CD19 on B cells (Maecker and Levy,
1997)/not studied
Antibody against CD81 suppresses
degranulation and PCA (Fleming et al.,
1997)
CD82 KAI1 4F9, C33,
GR15, IA4, R2,
SAR2, ST6,
TSPAN27
Risinger et al., 2014 Mild changes in phenotype, could lead to changes in
early establishment of proliferation and division when
challenged with a new environment (Risinger et al.,
2014)/not studied
CD151 GP27, MER2,
PETA-3, RAPH,
SFA1, TSPAN24
Wright et al., 2004; Sachs
et al., 2006
Bleeding (Wright et al., 2004), decreased
angiogenesis (Takeda et al., 2007), kidney failure
(Sachs et al., 2006)/increased late phase of PCA and
production of proinflammatory cytokines
(Abdala-Valencia et al., 2015)
CD151 is upregulated in MCs upon
FcεRI activation (Abdala-Valencia et al.,
2015)
secondary antibody (Hálová et al., 2013). Surprisingly, unlike
anti-CD63 (Kraft et al., 2005) or anti-CD81 (Fleming et al., 1997),
as discussed below, anti-CD9 did not modulate Ag-induced
degranulation (Hálová et al., 2013).
CD9 together with CD81 have been shown to co-localize
with a trimeric variant of FcεRI in human FcεRIpos dendritic
cells isolated from the skin of patients with atopic dermatitis.
In contrast, only moderate expression of CD9 and CD81 was
found on FcεRIneg monocytes (Peng et al., 2011). Concomitant
activation by FcεRI and CD9 crosslinking resulted in increased
interleukin (IL)-10 production compared to crosslinking of the
FcεRI alone. In contrast, co-activation of FcεRI with CD81 or
activation by aggregation of CD81 alone or CD9 alone had no
effect on IL-10 production (Peng et al., 1997). These data can
be taken as another evidence that CD9 and FcεRI are somehow
functionally cooperating.
Tetraspanins are well known regulators of chemotaxis and
migration in several cell types (Berditchevski, 2001; Boucheix and
Rubinstein, 2001). InMCs, IL-16 acts as a potent chemoattractant
(Qi et al., 2002). Surprisingly, chemotaxis of MCs toward IL-16
was blocked by anti-CD9 antibody or by reduced expression of
CD9 using RNA interference (RNAi) approach. These and other
findings led to the suggestion that CD9 acts as an alternate IL-
16 receptor (Qi et al., 2006). Studies with 2H9 anti-CD9 antibody
showed that intact IgG or its F(ab)2 fragment block chemotaxis of
MCs toward Ag, whereas Fab fragments had only minimal effects
on such chemotaxis. These findings suggest that inhibition of
chemotaxis toward Ag is caused by events induced by aggregation
of CD9 but does not require co-cross-linking of CD9 with FcγR.
Decreased expression of CD9 by lentiviral-induced RNAi CD9
knockdown (KD) did not affect migration toward Ag, suggesting
that CD9 is not involved in this process. However, the possibility
was not excluded that residual CD9 on the cell surface is involved
in the proper Ag-induced migration (Hálová et al., 2013).
CD63
CD63 was found to be located in the vicinity of FcεRI on RBL-
2H3 cells (Kitani et al., 1991). In MCs and basophils, CD63 is
expressed at the cell surface and at the membrane of secretory
lysosomes, including serotonin-containing granules that during
activation fuse with the plasma membrane. Therefore, CD63 is
extensively used as an activation marker of basophils. As the
response acts as “all-or-nothing” per cell, basophils either do
not bind the anti-CD63 mAb at all, or they bind a maximal
amount of the mAb, so that activated basophils can be easily
identified (Knol et al., 1991; Hoffmann et al., 2015). Unlike
basophils, a significant amount of CD63 is also expressed on
non-activated human MCs of different types, but similarly to
basophils it is also upregulated after activation (Valent et al.,
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FIGURE 2 | Topography of plasma membrane components in mast cells before and after activation with Ag or CD9-specific antibody. (A) In
non-activated cells, tetraspanin CD9 co-localizes with integrin in TEMs. These domains are topographically different from LAT- or NTAL-containing nanodomains, each
occupying a distinct plasma membrane region. FcεRI receptor is associated with LYN kinase in another membrane nanodomains. (B) Binding of Ag-specific IgE to
FcεRI, followed by exposure to multivalent Ag, causes multimerization of the FcεRI receptors. NTAL and LAT become phosphorylated, but are still separated in
different domains and do not co-localize with FcεRI and with each other. In contrast, antibody-mediated aggregation of CD9 brings CD9 into close proximity of NTAL
and FcγRs and causes NTAL phosphorylation. Activation through both FcεRI and CD9 leads to dephosphorylation of ERM and dynamic disconnection of the
membrane components and actin cytoskeleton. The conclusions indicated above are based on the interpretation of previously published data (Wilson et al., 2002;
Volná et al., 2004; Hálová et al., 2013).
2001). Recently, two structurally distinct isoforms of human
CD63 were identified, one characteristic of vesicles and another
expressed on the cell surface. Antibodies that differentiate
between these two isoforms are therefore prospective diagnostic
markers (Schäfer et al., 2010). Anti-CD63 mAb suppressed
degranulation of adherent (but not non-adherent) RBL-2H3
cells, whereas synthesis of leukotrienes (LTs) was not affected.
Initial stages of activation such as phosphorylation of signaling
proteins and Ca2+ responses were not inhibited by the antibody.
The ability of anti-CD63 mAb to suppress passive cutaneous
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anaphylaxis (PCA) in vivo makes CD63 a possible therapeutic
target (Kraft et al., 2005). As mice deficient in CD63 have been
recently prepared (Schröder et al., 2009), the role of CD63
for MC development and activation could be studied using
this model. Interestingly, although CD63 is highly expressed in
MCs, the number of MCs and their tissue distribution was not
altered in CD63 KO mice, and also MCs derived from bone
marrow of CD63 KO mice developed normally. When activated
with Ag, but not phorbol-12-myristate-13-acetate/ionomycin,
a significant decrease in FcεRI-mediated degranulation and
tumor necrosis factor (TNF)-α secretion was observed in CD63-
deficient BMMCs. On the other hand, secretion of IL-6 and LTC4
that are de novo synthetized upon activation was unaffected in
BMMCs with CD63 KO. This finding, together with the fact
that TNF-α is present in preformed granules, suggested that the
absence of CD63 in the secretory granules is the main cause of
reduced degranulation and TNF-α secretion (Kraft et al., 2013).
To test the role of CD63 in vivo, the authors introduced CD63
wild-type (WT) and KO MCs into mice of MC-deficient strain
Kitw/w−v and found out that mice reconstituted with CD63
KO MCs exhibited significantly decreased degranulation and
PCA. CD63-specific antibody, unlike CD9-specific antibody, was
unable to inhibit MC migration toward IL-16 (Qi et al., 2006).
CD81
Similarly to antibodies directed toward CD63 (see above),
mAb specific for CD81 was found to down-regulate FcεRI-
mediated degranulation in RBL-2H3 cells without affecting
initial tyrosine phosphorylation of signal-transduction proteins,
calcium response and synthesis of LTC4. The inhibitory effect of
anti-CD81 antibody was confirmed in vivo, where IgE-mediated
PCA in rats was significantly decreased (Fleming et al., 1997). On
the other hand, anti-CD81 antibody, unlike anti-CD9, was unable
to inhibit MC migration toward IL-16 (Qi et al., 2006).
Despite the fact that production of CD81 KO mice was
described almost 20 years ago (Maecker and Levy, 1997),
the role of CD81 in MC development or activation has not
been elucidated. A possible role of CD81 in MC activation
was suggested based on experiments in which allergen-induced
airway hyper-reactivity (AHR) was found to be diminished in
CD81 KO mice. These mice, in contrast to WT mice, once
challenged with ovalbumin (OVA) did not develop airway
inflammation characterized by the presence of inflammatory
cells, eosinophils, and synthesis of IL-4, IL-5, and IL-13 was
also dramatically reduced. On the other hand, the serum levels
of OVA-specific IgE were not changed (Deng et al., 2000). The
authors speculated that the reduced levels of cytokines could be
the reason of impaired MC activation in the absence of CD81
because anti-CD81 mAbs reduced MC activation. However, this
idea has never been proved.
CD151
Unlike other tetraspanins, CD151 was found to be upregulated
after activation of FcεRI in human and mouse MCs. Using
CD151 KO mice, Berdnikovs and colleagues studied the role of
CD151 in MC physiology (Abdala-Valencia et al., 2015). The
absence of CD151, did not lead to changes in degranulation
after Ag activation. On the other hand, mice with CD151 KO
exhibited a significant increase in magnitude of the late phase
of PCA response (24–36 h). In line with these findings, CD151-
deficient BMMCs showed enhanced production of several
proinflammatory cytokines, including IL-4, IL-13, and TNF-
α, which was probably related to the enhanced and sustained
FcεRI-induced extracellular signal-regulated kinase (ERK)1/2
and protein kinase B (PKB, also called AKT) phosphorylation in
these cells (Abdala-Valencia et al., 2015).
CD53
Although CD53 is expressed in MCs, there is only one study
showing association of CD53 with asthma risk via the functional
promoter polymorphism. Interestingly, siRNA-mediated KD of
CD53 in THP-1 human monocytic cells stimulated with house
dust mite led to increased production of inflammatory cytokines
as well as NFκB activity (Lee et al., 2013).
TRANSMEMBRANE ADAPTOR PROTEINS
Transmembrane adaptor proteins consist of a short extracellular
domain, a single transmembrane domain and a long cytoplasmic
tail. Extracellular domains are formed only by a few amino
acids, and are therefore unlikely to function as receptors for
extracellular ligands. The cytoplasmic tail possesses various
tyrosine-containing motifs that could act, after phosphorylation,
as scaffolds for anchor of multiple SRC homology (SH)2 domain-
containing cytoplasmic as well as membrane-associated proteins
and cytoskeletal components. As was already mentioned, most of
the TRAPs possess a juxtamembrane palmitoylation motif that
determines their solubility in non-ionic detergents, distribution
in the plasma membrane, and some functional properties. The
role of TRAPs in MC and leukocyte signaling has been recently
extensively reviewed (Draber et al., 2011a, 2016; Horejsi and
Hrdinka, 2014; Stepanek et al., 2014). Thus, this review is only
limited to a short description of some structural properties of
the most studied TRAPs in MCs that are important for the
membrane organization (Table 2).
LAT
The cytoplasmic tail of LAT contains nine highly conserved
tyrosine residues, of which five can be phosphorylated by spleen
tyrosine kinase (SYK) kinase upon activation and serve as
binding sites for SH2 domain-containing proteins including
growth factor receptor-bound protein 2 (GRB2), phospholipase
C (PLC)γ1, guanine nucleotide exchange factor VAV, ubiquitin
ligase CBL, SH2 domain-containing leukocyte protein of 76
kDa (SLP-76), and GRB2-related adaptor downstream of SHC
(GADS) (reviewed in Rivera, 2002, 2005; Draber et al., 2011a).
Although development of MCs was not affected in mice deficient
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TABLE 2 | Selected TRAPs expressed in mast cells and their function.
Gene
symbol
Most used aliases KO Phenotype of KO mice: general/in mast cells
LAT LAT1, pp36 Zhang et al., 1999 Defect in T-cell development—no mature T cells (Zhang et al., 1999)/reduced
degranulation, Ca2+ release and cytokine production, PSA (Saitoh et al., 2000)
LAT2 LAB, NTAL,
WBSCR15, WBSCR5
Volná et al., 2004; Zhu et al.,
2004
Increased levels of natural antibodies and humoral response (Wang et al., 2005)/increased
degranulation, Ca2+ release, cytokine production, PCA (Volná et al., 2004; Zhu et al.,
2004), and chemotaxis (Tumová et al., 2010)
PAG1 PAG, CBP Draberova et al., 2014 No visible changes in phenotype/reduced degranulation, Ca2+ release, cytokine
production, chemotaxis, PCA (Draberova et al., 2014)
LAX1 LAX Zhu et al., 2005a Reduction in CD23 expression on mature B cells, spontaneous germinal center formation,
hyper-responsiveness in T and B lymphocytes (Zhu et al., 2005a)/enhanced degranulation,
cytokine production, cell survival (Zhu et al., 2006)
GAPT Liu and Zhang, 2008 Increased B-cell proliferation and amount of Abs (Liu and Zhang, 2008)
in LAT (Saitoh et al., 2000), the mice exhibited reduced Ag-
mediated passive systemic anaphylaxis (PSA) responses. Ag-
stimulated BMMCs from LAT-deficient mice showed reduced
degranulation, Ca2+ release, and cytokine production (Saitoh
et al., 2000), whereas their chemotaxis was unchanged (Hálová
et al., 2013).
NTAL
NTAL shares several structural features with LAT, including
several tyrosine motifs of which five are the putative GRB2-
binding sites. However, there is nomajor homology in amino acid
sequences between these two adaptors and in contrast to LAT,
NTAL lacks the PLCγ1 binding motif. Similarly to LAT, NTAL
is rapidly phosphorylated upon Ag activation by SYK, and some
tyrosines are also phosphorylated by LYN. In contrast to LAT,
NTAL is also tyrosine phosphorylated upon c-KIT activation
by stem cell factor (SCF), LYN, and c-KIT itself (Iwaki et al.,
2008). Despite some similarities in features of LAT and NTAL
structures, BMMCs isolated from NTAL KO mice exhibited
increased degranulation, Ca2+ release, and cytokine production
(Volná et al., 2004; Zhu et al., 2004). Chemotaxis toward Ag
was also enhanced in NTAL-deficient cells (Tumová et al., 2010).
In accord with these observations, PCA of NTAL-KO mice was
also increased (Volná et al., 2004). Although it appeared that
LAT and NTAL act as opposite regulators of MC signaling, it
should be noted that the absence of both of them led to more
extensive inhibition of FcεRI-induced activation than the absence
of LAT alone (Volná et al., 2004; Zhu et al., 2004). Again, the
only exception was chemotaxis that was increased in double
KO cells compared to WT cells but still was lower than that in
NTAL-deficient cells (Hálová et al., 2013). These data indicate
that in the absence of NTAL, LAT acts as a negative regulator of
chemotaxis.
PAG
The structure of PAG is similar to that described for LAT
and NTAL, but in addition to 10 tyrosines, it possesses two
proline-rich domains that serve as binding sites for SH3 domains
and a C-terminal VTRL motif for interaction with the PDZ
domain of cytoskeletal linker ERM-binding protein of 50 kDa
(EBP50) (Brdicˇková et al., 2001). Upon FcεRI triggering, PAG is
phosphorylated by LYN in RBL-2H3 cells (Ohtake et al., 2002).
Phosphorylated tyrosine 317 (human) or 314 (mouse) is crucial
for binding of CSK. In RBL cells, overexpression of PAG led to
inhibition of receptor phosphorylation and subsequent decreased
degranulation (Ohtake et al., 2002). When BMMCs from mice
with PAG KO were analyzed, different findings were obtained.
PAG deficiency led to impaired Ag-induced degranulation,
extracellular Ca2+ uptake, tyrosine phosphorylation of several
proteins (including the FcεRI), production of cytokines and
chemokines, and also decreased chemotaxis (Draberova et al.,
2014). PAG-KO mice also exhibited impaired PCA. On the other
hand, activation through c-KIT led to increased degranulation,
suggesting different regulation of this TRAP after c-KIT and
FcεRI activation (Draberova et al., 2014).
LINKER FOR ACTIVATION OF X CELLS
(LAX)
LAX is another TRAP with multiple GRB2-binding motifs.
However, in contrast to LAT and NTAL, LAX has no
palmitoylation motif and is not localized in detergent-resistant
membranes (DRMs) (Zhu et al., 2002). LAX-deficient MCs
exhibited enhanced degranulation, enhanced activity of p38
mitogen-activated protein kinases (MAPK; PKB), and PI3K
activation after stimulation via FcεRI. Cytokine production and
cell survival were also enhanced in activated LAX-deficient cells.
On the other hand, the absence of LAX had no effect on calcium
response in vitro and PCA in vivo (Zhu et al., 2006).
GRB2-BINDING ADAPTOR PROTEIN,
TRANSMEMBRANE (GAPT)
GAPT has a short extracellular domain, a transmembrane
domain, and a cytoplasmic tail with multiple Grb2-binding
motifs. Similarly to LAX, GAPT does not reside in DRMs, even
though it contains potential palmitoylation sites similar to LAT
and NTAL. On the other hand, palmitoylation of GAPT has not
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been proved. In contrast to other mentioned TRAPs, GAPT is
not phosphorylated on tyrosine after FcεRI triggering (Liu and
Zhang, 2008).
MEMBRANE MICRO/NANO DOMAINS
OCCUPIED BY TETRASPANINS AND
TRAPS
Discovery of specific membrane domains came from the
studies of insoluble residues that remained after lysis of the
cells in buffers containing non-ionic detergents at 4◦C. These
DRMs formed predominantly by sphingolipids, cholesterol and
proteins, were proposed to play key roles inmembrane trafficking
and signaling (Simons and Ikonen, 1997). Studies of DRMs were
accelerated by development of the method of their isolation by
sucrose density gradient centrifugation of cells lysed in non-ionic
detergents. Both tetraspanins and palmitoylated TRAPs were
found to be associated with DRMs. The effect of palmitoylation
on the presence of these proteins in DRMs is discussed below.
Based on the differences in detergent sensitivity, TEMs, or
tetraspanin web, were identified as novel structures different from
glycosylphosphatidylinositol (GPI)-microdomains and caveolae.
It has been proposed that TEMs are involved in the plasma
membrane organization through tetraspanin-tetraspanin and
tetraspanin-other protein interaction (Boucheix and Rubinstein,
2001; Claas et al., 2001). In their sensitivity to different non-
ionic detergents, protein-protein and protein-lipid interactions
in TEMs differ from those in TRAP-enriched domains. Whereas
tetraspanin-tetraspanin interactions are preserved in nonionic
detergents Brij 58, Brij 97, Brij 98, and CHAPS, Triton X-
100 disrupts the majority of these interactions along with
participation of tetraspanins in sucrose low-density fractions.
On the other hand, lysis in Brij detergents at 37◦C disrupts
GPI-microdomains but not TEMs (Claas et al., 2001; Charrin
et al., 2003a, 2009). Tetraspanins were found to directly interact
with cholesterol (Charrin et al., 2003b). Furthermore, it has
been described that tetraspanins CD82 interacts with ganglioside
GM2 (Todeschini et al., 2007), tetraspanin CD9 binds to
GM3 (Kawakami et al., 2002) and that these interactions are
important for the association of these tetraspanins with integrins.
Since the concept of TEMs was proposed, most interactions of
tetraspanins with their partners (e.g., tetraspanins and integrins)
were identified by co-immunoprecipitation experiments after
lysis of the cells in mild detergents. Some of them were later
confirmed by crosslinking experiments or Förster resonance
transfer (FRET) analysis (Boucheix and Rubinstein, 2001).
The existence of specific membrane domains that are
dependent on lipid composition was at first deduced on the
basis of experiments with detergent solubility/insolubility of
individual membrane proteins and the term DRMs was coined.
Discovery and use of modern high-resolution techniques, such
as (FRET; McIntosh et al., 2012), fluorescence recovery after
photobleaching (FRAP; Axelrod et al., 1976), stimulated emission
depletion (STED; Auksorius et al., 2008), photoactivated
localization microscopy (PALM; Betzig et al., 2006), and
stochastic optical reconstruction microscopy (STORM; Rust
et al., 2006) contributed significantly to identifying the real
interactions on the plasma membrane components under in vivo
conditions. The first results obtained with the high-resolution
microscopic techniques (Kenworthy et al., 2000, 2004; Glebov
and Nichols, 2004) challenged the theories based on detergent
solubility. As more studies appeared, it was apparent that the
majority of the results are basically in accord with the existence of
plasma membrane domains, which are, however, of smaller size
than previously thought, and therefore the term nanodomains
was more often used for marking small dynamic domains that
vary in time and size and which are enriched in cholesterol and
sphingolipids.
Regarding tetraspanins, single-molecule fluorescence
microscopy of living cells revealed that tetraspanin assemblies
form dynamic interaction platforms in permanent exchange
with the rest of the membrane. Tracking of tetraspanin CD9
showed that most of the time it was undergoing Brownian
trajectories, but it was transiently trapped in platforms enriched
in CD9 and its partners. Both the mobility and partitioning in
the nanodomains were dependent on palmitoylation and plasma
membrane cholesterol (Espenel et al., 2008). FRET-FLIM analysis
revealed homophilic (CD9-CD9) and heterophilic (CD9-CD151)
tetraspanin interactions as well as their interaction with adhesion
molecules, with preferential association of CD9 with intercellular
adhesion molecule 1 (ICAM-1, also known as CD54) and of
CD151 with vascular cell adhesion molecule 1 (VCAM-1, also
known as CD106). FRAP analysis also revealed that a marker of
membranemicrodomains, rGPI-EGFP, diffusedmuch faster than
tetraspanins (Barreiro et al., 2008; Ley and Zhang, 2008). On the
other hand, recent work analyzed TEMs by STED microscopy
and showed that tetraspanins form individual nanoclusters. It
was also demonstrated that CD53 and CD37 domains showed
only minor overlap with clusters containing tetraspanins CD81
or CD82. It should be also noted that CD53 and CD81 reside
in closer proximity to their partners, major histocompatibility
complex (MHC) class II and CD19, respectively, than to other
tetraspanins (Zuidscherwoude et al., 2015).
When TRAPs were examined, using cells solubilized with
non-ionic detergents, LAT was found in DRMs (Zhang et al.,
1998). In contrast, FcεRI was not present in such domains
before activation, but once aggregated, FcεRI became associated
with DRMs. It has been suggested that association of FcεRI
with DRMs is a prerequisite for FcεRI activation because in
DRMs, FcεRI is phosphorylated by SRC family kinase LYN,
which is resident in DRMs (Field et al., 1995; Dráberová et al.,
2004). However, immunogold electron microscopy studies of
isolated plasma membrane sheets did not prove co-localization
of aggregated FcεRI and LAT, even though both domains were
increased in size (Wilson et al., 2001, 2002; Lebduška et al.,
2007). Scanning electron microscopy revealed that activation
of RBL cells with Ag causes redistribution of LAT in the
plasma membrane, where upon activation LAT was found in
bigger clusters than before activation (Veatch et al., 2012).
Although the studies did not examine whether LAT clusters
co-localize with FcεRI clusters the data clearly showed that
aggregation of FcεRIs causes redistribution of LAT. Recent
studies of LAT clustering in resting and activated T cells by
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PALM (Betzig et al., 2006) and direct STORM (Rust et al., 2006)
revealed that increase of LAT clusters after activation is due
to the translocation of LAT from subsynaptic vesicles to cell
surface and this recruitment is essential for LAT phosphorylation
(Williamson et al., 2011). In another study with single and two-
color PALM Sherman and collaborators showed that in resting
and activated T cells LAT primarily resides in nanoscale clusters
as small as dimers whose formation depended on protein-
protein and protein-lipid interactions (Sherman et al., 2011).
Furthermore, Lillemeier and collaborators used high-speed
version of photoactivated localization microscopy (hsPALM),
dual-color fluorescence cross-correlation spectroscopy (dsFCCS)
and transmission electron microscopy and showed that both the
T cell receptor (TCR) and LAT are preclustered into separate
and spatially separated membrane domains on quiescent cells.
After Ag recognition, these domains transiently concatenated
into microclusters without any substantial change in the size
and number of the component domains. These data suggest that
partitioning immunoreceptors and their downstream signaling
components into separate membrane domains, and then
bringing these domains together, may be an important and
general mechanism in the control of cell activation (Lillemeier
et al., 2016). In another study, analysis of LAT in the plasma
membrane of HeLa cells by fluorescence correlation spectroscopy
(FCS) and PALM showed that LAT diffusion is retarded and
its clustering in meso-scaled protein domains is decreased
when associating with ordered-lipid domains in contrast to
LAT associating with lipid-disordered domains (Owen et al.,
2012). Importance of cholesterol for formation of DRMs and for
immunoreceptor signaling has been repeatedly shown (Xavier
et al., 1998; Sheets et al., 1999; Surviladze et al., 2001). It
should also be noted that FcεRI-mediated activation is affected
by ethanol, which seems to interfere with proper function of
FcεRI-cholesterol signalosomes (Draberova et al., 2015) and
that phosphatase inhibitor, pervanadate, induces FcεRI β and
γ subunits tyrosine phosphorylation in the absence of FcεRI
aggregation and its association with DRMs (Heneberg et al.,
2010).
PALMITOYLATION OF TETRASPANINS
AND TRAPS
Palmitoylation is a reversible lipid post-translational
modification of juxtamembrane cysteine residues, less frequently
also serine and threonine, in a variety of transmembrane or
membrane-associated proteins (Resh, 1999). Palmitoylation also
allows such modified proteins to float in the low-density fraction
of sucrose gradient after lysis in non-ionic detergents (Charrin
et al., 2002, 2009; Stepanek et al., 2014). However, loss of
palmitoylation of tetraspanins and TRAPs had a different impact
on their solubility in non-ionic detergents and interactions with
their partners. It has been shown that palmitoylation of CD151
had minimal influence on the density of tetraspanin-protein
complexes and did not promote tetraspanin localization into
DRMs or its association with α3β1 integrin, but its association
with other cell surface proteins, including CD9 and CD63,
was reduced (Yang et al., 2002). The palmitoylation of CD9
did not influence its localization into DRMs but was necessary
for its interaction with other tetraspanins, namely CD81
and CD53 (Charrin et al., 2002). Similar observations were
obtained when membrane compartmentalization of integrins
had been studied. It has been suggested that palmitoylation of
β4 promotes its association with DRMs and SRC family kinases
(Gagnoux-Palacios et al., 2003) but further studies showed that
β4 palmitoylation does not increase its localization into DRMs,
instead it promotes CD151–α6β4 incorporation into a network
of secondary tetraspanin interactions (Yang et al., 2004).
Although importance of palmitoylation for proper function
of TRAPs has been shown, it still remains in part controversial.
LAT is palmitoylated at C26 and C29 and this event is crucial
for LAT association with DRMs and proper immunoreceptor
function (Zhang et al., 1998; Levental et al., 2010). An important
question was whether palmitoylation is also important for plasma
membrane localization. It has been reported that the LAT
mutated in the cysteines separately or together was localized into
the plasmamembrane of HEK cells (Zhang et al., 1998). However
in this study LAT was not examined for its co-localization
with plasma membrane markers. Recent studies showed that
palmitoylation at C26 is essential for transporting of LAT from
Golgi to plasma membrane (Hundt et al., 2009; Chum et al.,
2016). In contrast, surprisingly, NTAL and PAG did not require
palmitoylation for plasma membrane localization (Chum et al.,
2016).
In another study, mutant LAT was constructed, in
which transmembrane domain of LAT was exchanged with
transmembrane domain of LAX, another TRAP, that lacks
palmitoylation motifs, but possesses LAX transmembrane
signal peptide that provides localization of the LAX in plasma
membrane. This LAX-LAT protein was not detected in DRMs
but appeared to be fully functional in T cell activation and
development (Zhu et al., 2005b). Similar results were obtained
when SRC-LAT mutant was constructed and examined in
similar assays. The mutant protein was localized as peripheral
membrane protein through myristoylation of its SRC domain
but it was excluded from DRMs and appeared to be fully
functional in TCR signaling (Hundt et al., 2009). Later studies
of LAX-LAT mutant protein showed that it is localized in an
atypical DRMs—called “heavy” DRMs (Otáhal et al., 2010).
When CD25-LAT mutant was used, it was excluded from both
DRMs and “heavy” DRMs (Otáhal et al., 2010). This study also
demonstrated that the level of exogenous construct expression
is critical for proper interpretation of the results. At the levels of
expression, corresponding to the expression level of endogenous
LAT, WT LAT, present mostly in DRMs, supported signaling
better than LAX–LAT mutant; the CD25-LAT mutant was the
least effective in the assay (Otáhal et al., 2010). Importance of
palmitoylation for association with DRMs was also shown in
studies with mutant LYN kinase in RBL cells. LYN mutated in
both palmitoylation and myristoylation sites, did not anchor to
the plasma membrane, whereas LYN with only palmitoylation
site mutated was anchored to the plasma membrane, but its
localization into DRMs was markedly reduced (Kovárová
et al., 2001). Interestingly, studies with RBL cells showed that
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clustering of FcεRI led to co-clustering with LYN, depending on
the presence of cholesterol (Veatch et al., 2012). Furthermore,
FcεRI motility in the plasma membrane after Ag triggering was
also dependent on cholesterol levels (Shelby et al., 2013).
TETRASPANINS AND TRAPS CROSS-TALK
Electron microscopy studies showed that LAT and NTAL,
despite their structural similarities and proved association with
DRMs, occupy separate membrane microdomains in MCs
(Volná et al., 2004). The differences between the LAT and
NTAL microdomains were confirmed in experiments in which
topography of CD9 and TRAPs in the plasma membrane was
examined: while NTAL co-localized with CD9, LAT did not
(Hálová et al., 2013). CD9-NTAL co-localization was intensified
by crosslinking CD9 with specific mAb, and this crosslinking
resulted in enhanced phosphorylation of NTAL (Hálová et al.,
2013). There are other examples of interaction between TRAPs
and tetraspanins. Two recently identified TRAPs, SLP65/SLP76,
Csk-interacting membrane protein (SCIMP) and leukocyte-
specific transcript 1/A (LST1/A) were found to interact with
tetraspanins (Draber et al., 2011b, 2012). SCIMP, which is
expressed in B cells and other professional Ag-presenting cells,
co-localized with tetraspanins CD81 and CD37 (Draber et al.,
2011b), whereas LST1/A, which is expressed exclusively in
the cells of myeloid origin (monocytes and granulocytes), co-
localized with tetraspanins CD9 and CD81 (Draber et al., 2012).
Both tetraspanins and TRAPs were found to function
as direct or indirect linkers of the plasma membrane and
cytoskeleton. Co-immunoprecipitation studies showed that
tetraspanins CD9 and CD81 are associated with ERM proteins,
which directly interact with the cytoskeleton (Sala-Valdés et al.,
2006). ERM proteins link plasma membrane phospholipids by
binding their N-terminal FERM (4.1, ezrin/radixin/moesin)
domain to phosphatidylinositol (4,5) bisphosphate (PIP2)
and the actin cytoskeleton through the actin-binding
domain (Abd) at the C-terminus. This binding is a highly
dynamic process dependent on ERM 567/564/558 threonine
phosphorylation/dephosphorylation. ERMs are released from the
membrane when their inhibitory threonine is dephosporylated
and ERMs are transformed from “open” phosphorylated
to “closed” dephosphorylated conformation (McClatchey,
2014). However, it has not been clarified whether interactions
between tetraspanins and ERMs are direct or indirect through
tetraspanin-interacting proteins CD9P-1 and/or EWI-2 (Sala-
Valdés et al., 2006). Earlier studies showed that engaging CD81
at the surface of B cells led to phosphorylation of ezrin by
the SYK kinase (Coffey et al., 2009). In MCs, crosslinking of
CD9 with mAb led to dephosphorylation of ERM inhibitory
threonine (Hálová et al., 2013). TRAP PAG also interacts with
ezrin, but in this case through ERM-binding phosphoprotein of
50 kDa (EBP50). In this binding, the N-terminal PDZ domain of
EBP50 and C-terminal domain of PAG are involved (Brdicˇková
et al., 2001). The ezrin-EBP50-PAG complex was found to be
important for the spatio-temporal control of cAMP production
through the CSK-PAG inhibitory pathway in effector T cells
(Cornez and Taskén, 2010).
CONCLUDING REMARKS AND
PERSPECTIVES
Although knowledge about tetraspanins and TRAPs at the
level of proteins and the corresponding genes and their
regulators is increasing, their functioning as platforms of
plasma membrane signalosomes and their mutual crosstalk
are far from understood. The exact composition of TEMs
and TRAPs-enriched domains is also poorly defined. This
is in part due to highly dynamic nature of the membrane
domains and the large number of various lipids involved.
Lipids function not only as a matrix in which tetraspanins,
TRAPs, and other membrane proteins are anchored, but also
as modifiers of various proteins. When focusing specifically on
signal transduction in MCs, there are also many poorly explored
areas, which include potential roles of various post-translational
modifications on topography and function of the tetraspanins
and TRAPs and their interaction partners. An important area
to explore is the role of miRNAs, noncoding RNAs, and other
regulators of tetraspanins and TRAPs expression (Zhang et al.,
2014; Rouquette-Jazdanian et al., 2015). As shown in this
review focused on MCs, important discoveries concerning the
role of individual members of tetraspanins and TRAPs were
brought by studies based on cells deficient in selected proteins
through the gene KO or KD approach. However, with the
armamentarium of proteomics, lipidomics, epigenetics, super-
resolution microscopy, multi-photon microscopy, etc., our pace
of discoveries in the field of specific membrane nanodomains
will be accelerated in the next few years. Most of the studies
mentioned in this review were performed using cells cultured
under in vitro conditions. However, one needs to understand
more on how TEMs and TRAPs-enriched domains function
under in vivo conditions. This issue involves not only the
influence of various soluble factors that are absent in cell
culture media, but also the interaction with other cells and
extracellular matrix components that could influence functions
of the tetraspanins and their interaction partners. Such type of
studies in the case of MCs will deepen our understanding
of the cellular and molecular mechanisms underlying allergic
diseases.
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